Oakworth Capital, Inc. Amgen Inc Transaction History

Oakworth Capital, Inc.

$1.44 Billion
Q3 2024

A detailed history of Oakworth Capital, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Oakworth Capital, Inc. holds 1,505 shares of AMGN stock, worth $409,525. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,505

Previous 1,222 23.16%

Holding current value

$409,525

Previous $381,000 27.03%

% of portfolio

0.03%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$309.38 - $337.38 $87,554 - $95,478	283 Added 23.16%	1,505 $484,000
Q2 2024 Jul 19, 2024	SELL	$262.75 - $319.31 $32,055 - $38,955	-122 Reduced 9.08%	1,222 $381,000
Q1 2024 Apr 22, 2024	SELL	$268.87 - $324.56 $27,155 - $32,780	-101 Reduced 6.99%	1,344 $382,000
Q4 2023 Jan 30, 2024	BUY	$255.7 - $288.46 $186,149 - $209,998	728 Added 101.53%	1,445 $416,000
Q3 2023 Oct 31, 2023	SELL	$218.65 - $271.46 $218 - $271	-1 Reduced 0.14%	717 $192,000
Q2 2023 Jul 28, 2023	BUY	$214.27 - $253.37 $47,139 - $55,741	220 Added 44.18%	718 $159,000
Q3 2022 Oct 31, 2022	BUY	$224.46 - $253.15 $29,628 - $33,415	132 Added 36.07%	498 $112,000
Q2 2022 Aug 05, 2022	SELL	$230.71 - $256.74 $19,148 - $21,309	-83 Reduced 18.49%	366 $89,000
Q3 2021 Nov 10, 2021	SELL	$212.27 - $248.7 $244,322 - $286,253	-1,151 Reduced 71.94%	449 $95,000
Q2 2021 Jul 20, 2021	SELL	$233.58 - $259.14 $104,410 - $115,835	-447 Reduced 21.84%	1,600 $390,000
Q1 2021 Apr 30, 2021	BUY	$221.91 - $258.6 $55,477 - $64,650	250 Added 13.91%	2,047 $509,000
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $32,457 - $38,650	150 Added 9.11%	1,797 $413,000
Q3 2020 Nov 09, 2020	BUY	$234.65 - $260.95 $82,362 - $91,593	351 Added 27.08%	1,647 $419,000
Q1 2020 May 07, 2020	BUY	$182.24 - $241.7 $126,292 - $167,498	693 Added 114.93%	1,296 $263,000
Q4 2019 Jan 31, 2020	BUY	$189.21 - $243.2 $73,602 - $94,604	389 Added 181.78%	603 $144,000
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $2,263 - $2,712	-13 Reduced 5.73%	214 $41,000
Q2 2019 Aug 02, 2019	SELL	$166.7 - $195.41 $14,002 - $16,414	-84 Reduced 27.01%	227 $42,000
Q1 2019 May 06, 2019	SELL	$180.87 - $203.88 $18,448 - $20,795	-102 Reduced 24.7%	311 $59,000
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $17,840 - $20,825	-100 Reduced 19.49%	413 $80,000
Q1 2018 May 09, 2018	SELL	$169.43 - $198.0 $3,558 - $4,158	-21 Reduced 3.93%	513 $90,000
Q4 2017 Jan 22, 2018	SELL	$168.79 - $188.59 $33,758 - $37,718	-200 Reduced 27.25%	534 $94,000
Q3 2017 Nov 08, 2017	BUY	$167.29 - $191.0 $122,790 - $140,194	734	734 $130,000

Others Institutions Holding AMGN

# of Institutions

3,097

Shares Held

406M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oakworth Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oakworth Capital, Inc. with notifications on news.

Account

Oakworth Capital, Inc. Amgen Inc Transaction History